Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR201306000510382Not yet recruiting
Randomised, open-label trial comparing Spinal lignocaine with Spinal bupivacaine (2 arms). Primary endpoint: Incidence of transient neurologic symptoms. Planned start Mar 2013; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR201306000510382.